234 related articles for article (PubMed ID: 21261639)
1. Anti-diabetic effects of resveratrol.
Szkudelski T; Szkudelska K
Ann N Y Acad Sci; 2011 Jan; 1215():34-9. PubMed ID: 21261639
[TBL] [Abstract][Full Text] [Related]
2. Resveratrol and diabetes: from animal to human studies.
Szkudelski T; Szkudelska K
Biochim Biophys Acta; 2015 Jun; 1852(6):1145-54. PubMed ID: 25445538
[TBL] [Abstract][Full Text] [Related]
3. Protection of pancreatic beta-cells: is it feasible?
Bonora E
Nutr Metab Cardiovasc Dis; 2008 Jan; 18(1):74-83. PubMed ID: 18096375
[TBL] [Abstract][Full Text] [Related]
4. Ameliorative potential of resveratrol on proinflammatory cytokines, hyperglycemia mediated oxidative stress, and pancreatic beta-cell dysfunction in streptozotocin-nicotinamide-induced diabetic rats.
Palsamy P; Subramanian S
J Cell Physiol; 2010 Aug; 224(2):423-32. PubMed ID: 20333650
[TBL] [Abstract][Full Text] [Related]
5. Resveratrol and diabetes: A critical review of clinical studies.
Öztürk E; Arslan AKK; Yerer MB; Bishayee A
Biomed Pharmacother; 2017 Nov; 95():230-234. PubMed ID: 28843911
[TBL] [Abstract][Full Text] [Related]
6. Resveratrol, obesity and diabetes.
Szkudelska K; Szkudelski T
Eur J Pharmacol; 2010 Jun; 635(1-3):1-8. PubMed ID: 20303945
[TBL] [Abstract][Full Text] [Related]
7. Resveratrol improves insulin sensitivity, reduces oxidative stress and activates the Akt pathway in type 2 diabetic patients.
Brasnyó P; Molnár GA; Mohás M; Markó L; Laczy B; Cseh J; Mikolás E; Szijártó IA; Mérei A; Halmai R; Mészáros LG; Sümegi B; Wittmann I
Br J Nutr; 2011 Aug; 106(3):383-9. PubMed ID: 21385509
[TBL] [Abstract][Full Text] [Related]
8. Secondary diabetes associated with principal endocrinopathies: the impact of new treatment modalities.
Resmini E; Minuto F; Colao A; Ferone D
Acta Diabetol; 2009 Jun; 46(2):85-95. PubMed ID: 19322513
[TBL] [Abstract][Full Text] [Related]
9. TAK-875, an orally available G protein-coupled receptor 40/free fatty acid receptor 1 agonist, enhances glucose-dependent insulin secretion and improves both postprandial and fasting hyperglycemia in type 2 diabetic rats.
Tsujihata Y; Ito R; Suzuki M; Harada A; Negoro N; Yasuma T; Momose Y; Takeuchi K
J Pharmacol Exp Ther; 2011 Oct; 339(1):228-37. PubMed ID: 21752941
[TBL] [Abstract][Full Text] [Related]
10. Anti-diabetic effects of Centratherum anthelminticum seeds methanolic fraction on pancreatic cells, β-TC6 and its alleviating role in type 2 diabetic rats.
Arya A; Looi CY; Cheah SC; Mustafa MR; Mohd MA
J Ethnopharmacol; 2012 Oct; 144(1):22-32. PubMed ID: 22954496
[TBL] [Abstract][Full Text] [Related]
11. On high-frequency insulin oscillations.
Schmitz O; Rungby J; Edge L; Juhl CB
Ageing Res Rev; 2008 Dec; 7(4):301-5. PubMed ID: 18583199
[TBL] [Abstract][Full Text] [Related]
12. Energy restriction prevents the development of type 2 diabetes in Zucker diabetic fatty rats: coordinated patterns of gene expression for energy metabolism in insulin-sensitive tissues and pancreatic islets determined by oligonucleotide microarray analysis.
Colombo M; Kruhoeffer M; Gregersen S; Agger A; Jeppesen P; Oerntoft T; Hermansen K
Metabolism; 2006 Jan; 55(1):43-52. PubMed ID: 16324918
[TBL] [Abstract][Full Text] [Related]
13. Resveratrol, a red wine antioxidant, possesses an insulin-like effect in streptozotocin-induced diabetic rats.
Su HC; Hung LM; Chen JK
Am J Physiol Endocrinol Metab; 2006 Jun; 290(6):E1339-46. PubMed ID: 16434553
[TBL] [Abstract][Full Text] [Related]
14. Role of resveratrol in the management of insulin resistance and related conditions: Mechanism of action.
Abbasi Oshaghi E; Goodarzi MT; Higgins V; Adeli K
Crit Rev Clin Lab Sci; 2017 Jun; 54(4):267-293. PubMed ID: 28704113
[TBL] [Abstract][Full Text] [Related]
15. The role of resveratrol in diabetes and obesity associated with insulin resistance.
Hoca M; Becer E; Vatansever HS
Arch Physiol Biochem; 2023 Apr; 129(2):555-561. PubMed ID: 33719825
[TBL] [Abstract][Full Text] [Related]
16. Reduction of oxidative stress by a new low-molecular-weight antioxidant improves metabolic alterations in a nonobese mouse diabetes model.
Novelli M; D'Aleo V; Lupi R; Paolini M; Soleti A; Marchetti P; Masiello P
Pancreas; 2007 Nov; 35(4):e10-7. PubMed ID: 18090226
[TBL] [Abstract][Full Text] [Related]
17. Application of resveratrol in diabetes: rationale, strategies and challenges.
Bagul PK; Banerjee SK
Curr Mol Med; 2015; 15(4):312-30. PubMed ID: 25941821
[TBL] [Abstract][Full Text] [Related]
18. Anti-inflammatory properties of resveratrol in the retinas of type 2 diabetic rats.
Ghadiri Soufi F; Arbabi-Aval E; Rezaei Kanavi M; Ahmadieh H
Clin Exp Pharmacol Physiol; 2015 Jan; 42(1):63-8. PubMed ID: 25371281
[TBL] [Abstract][Full Text] [Related]
19. Pharmacodynamic effects of oral contraceptive steroids on biochemical markers for arterial thrombosis. Studies in non-diabetic women and in women with insulin-dependent diabetes mellitus.
Petersen KR
Dan Med Bull; 2002 Feb; 49(1):43-60. PubMed ID: 11894723
[TBL] [Abstract][Full Text] [Related]
20. Resveratrol modulates adipokine expression and improves insulin sensitivity in adipocytes: Relative to inhibition of inflammatory responses.
Kang L; Heng W; Yuan A; Baolin L; Fang H
Biochimie; 2010 Jul; 92(7):789-96. PubMed ID: 20188786
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
